9-Step Magnetic Bariatric Revisional Surgery

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorUnidad Internacional de Cirugia Bariatrica y Metabolica

About this trial

RYGB represents one of the best alternatives for weight loss in obese patients achieving a weight loss of up to 60% and a resolution of comorbidities of 70%. Revision surgery contemplates multiple techniques including the conversion from one surgical technique to another, structural changes to the primary technique, among others. GERD is now a long-term problem for patients who have undergone LGS. RYGB is one of the best techniques to resolve this problem.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Older than 18 years

Candidate to bariatric surgery

Obesity

BMI Greater than 30 kg/m2

Disqualifiers

Uncontrolled co-morbidities

patients with pacemakers, defibrillators, or other electromedical implants

Abnormal coagulation blood tests

Patients with hepatic diseases

Trial population

Patients candidates to bariatric surgery in the international unit of bariatric and metabolic surgery

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • magnetic bariatric surgery

    Procedure/Surgery

    Perform a roux-en-y gastric bypass, sleeve gastrectomy, nissen-sleeve or revisional bariatric procedure with magnetic assistance

  • Magnetic gastric bypass

    Procedure/Surgery

    Using the magnetic assistance to perform a gastric bypass

Treatment groups

500 Participants
are divided into 1 treatment group
Group A: Magnetic bariatric surgery2 interventions

Trial outcomes

Primary outcomes

1

complications

adverse surgical events

Time frame
30 days
2

device malfunction

any adverse event with the magnetic grasper

Time frame
1-2 hours
3

surgical time

report the surgical time using the magnetic assistance

Time frame
30 days

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.